Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02512926
Title Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Phoenix Children's Hospital
Indications

leukemia

Therapies

Cyclophosphamide

Carfilzomib

Etoposide

Age Groups: adult | child
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Phoenix Children's Hospital Recruiting Phoenix Arizona 85016 United States Details
Arkansas Children's Hospital Recruiting Little Rock Arkansas 72202 United States Details
Stanford University School of Medicine and Stanford Cancer Institute Recruiting Palo Alto California 94304 United States Details
Dana Farber Cancer Institute Active, not recruiting Boston Massachusetts 02215 United States Details
Memorial Sloan-Kettering Cancer Center Recruiting New York New York 10065 United States Details
Penn State Hershey Children's Hospital Recruiting Hershey Pennsylvania 17033-0850 United States Details
University of Texas Health Science Center at San Antonio Recruiting San Antonio Texas 78229 United States Details
Alberta Children's Hospital Recruiting Calgary Alberta T3B 6A8 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field